Considering the widespread but variable expression of GR in cancer, it must be assumed that the application of steroids can also directly impact cancer cells and exert clinical effects that may remain clinically unrecognized in the context of severe illness in affected patients. The gene discussed is NR3C1; the disease is cancer.